CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 110 enrolled
Drug / intervention
Red blood cell transfusionbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01167582
NCT01167582Phase 3Completed
CompareCT.gov

Myocardial Ischemia and Transfusion Pilot

Rutgers, The State University of New Jersey·interventional·Posted Jul 22, 2010·Updated Mar 20, 2019

In Brief

A Phase 3 clinical trial evaluating Red blood cell transfusion for Myocardial Infarction and 2 related conditions. Completed, enrolled 110 participants across 7 sites.

Detailed Summary

The purpose of this study is to evaluate two approaches to red blood cell transfusion in anemic patients with acute coronary syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyocardial Infarction, Unstable Angina, Coronary Artery Disease
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), University of Pittsburgh, Albert Einstein College of Medicine, Brigham and Women's Hospital, Rhode Island Hospital

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 22, 2010
Enrollment StartSep 1, 2009
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 15.9 years ago

Interventions

Red blood cell transfusionbiological

Liberal versus restrictive transfusion